Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
12/19/2012 | CN102824383A Method for extracting madagascar periwinkle herb total alkaloid |
12/19/2012 | CN102824381A Isatis root and vitamin C tablet and preparation method thereof |
12/19/2012 | CN102824380A Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation |
12/19/2012 | CN102824376A Cordyceps sinensis powder and preparation method and application thereof |
12/19/2012 | CN102824375A Application of Wuling capsule in preparation of medicament for inhibiting proliferation of U251 cell |
12/19/2012 | CN102824352A Application of disaccharide compound in preparing anti-tumor medicine |
12/19/2012 | CN102824351A Application of disaccharide compound in preparation of antiviral drug |
12/19/2012 | CN102824348A New technology for extracting sterol from corn germ oil deodorization distillate |
12/19/2012 | CN102824347A Application of securinine in preparing medicine for suppressing MDA-MB-157 cell proliferation |
12/19/2012 | CN102824346A Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin |
12/19/2012 | CN102824345A Irinotecan hydrochloride composition and preparation method thereof |
12/19/2012 | CN102824344A Pharmaceutical composition utilizing berberine to inhibit cancer stem cell growth or cancer cell metastasis, and application thereof |
12/19/2012 | CN102824334A Anti-cancer drug |
12/19/2012 | CN102824325A Quercetin sustained release tablet and preparing method thereof |
12/19/2012 | CN102824320A Phytosterol tablet and preparation method thereof |
12/19/2012 | CN102824306A Folic acid modified chitosan coated plasmid nanoparticles and preparation method thereof |
12/19/2012 | CN102823792A Soft propolis astragalus mongholicus capsule and preparation method thereof |
12/19/2012 | CN102379860B Biological illuminated drug carrier and preparation method thereof |
12/19/2012 | CN102293765B Application of isoflavone compound to preparation of antitumor medicines or food |
12/19/2012 | CN102286324B Method for preparing gingko golden fungus fruit wine |
12/19/2012 | CN102268099B Rangoon creeper fruit extract and extraction method thereof |
12/19/2012 | CN102180985B Method for extracting and purifying mugwort polysaccharides |
12/19/2012 | CN102154206B Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell |
12/19/2012 | CN102038959B Application of let-7/miR-98 family in preparation of medicament for treating disease related to FAS (Fatty Acid Synthase) gene |
12/19/2012 | CN102008475B Application of quinolizidine in preparing tumor treatment drugs |
12/19/2012 | CN101974535B Preparation and application of novel anti-ErbB2 humanized antibody MIL12 |
12/19/2012 | CN101780150B Plant extract and pharmaceutical composition for treating cough and preparation method thereof |
12/19/2012 | CN101732720B Preparation and application of anti-cancer medicament carrier with dual functions of targeting and fluorescence |
12/19/2012 | CN101596159B New taxol injection and preparation method thereof |
12/19/2012 | CN101574375B Lactobacillus health-care capsule and preparation method thereof |
12/19/2012 | CN101538258B Compound of salvia miltiorrhiza and derivative, preparation method and medicine application thereof |
12/19/2012 | CN101495148B Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
12/19/2012 | CN101337992B Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof |
12/19/2012 | CN101115728B Triazole substituted aminobenzophenone compounds |
12/18/2012 | US8334370 Polynucleotides comprising intercalating entities |
12/18/2012 | US8334313 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
12/18/2012 | US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use |
12/18/2012 | US8333961 Natural liniment for treatment of skin cancers |
12/18/2012 | US8333958 HSA-free formulations of interferon-Beta |
12/18/2012 | US8333953 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
12/18/2012 | CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
12/18/2012 | CA2720944C Compounds and compositions as kinase inhibitors |
12/18/2012 | CA2589421C Erbb3 antibodies |
12/18/2012 | CA2514552C Adjuvant used in dielectric heating-assisted cancer treatment, and cancer treatment method |
12/18/2012 | CA2504665C Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia |
12/18/2012 | CA2472163C Psoriasin expression by breast epithelial cells |
12/18/2012 | CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
12/18/2012 | CA2345109C Receptor based antagonists and methods of making and using |
12/13/2012 | WO2012171024A2 Enzyme directed assembly of particle theranostics |
12/13/2012 | WO2012171020A1 Protein-polymer-drug conjugates |
12/13/2012 | WO2012171007A2 Methods for treating or preventing graft versus host disease |
12/13/2012 | WO2012171002A1 Synthesis and characterization of second generation benzofuranone ring substituted noscapine analogs |
12/13/2012 | WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
12/13/2012 | WO2012170929A2 Monoclonal antibody and antigens for diagnosing and treating lung disease and injury |
12/13/2012 | WO2012170785A1 Anti-cd22 antigen binding molecules to treat lung cancer and prostate cancer |
12/13/2012 | WO2012170776A2 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy |
12/13/2012 | WO2012170742A2 Treatment and prevention of cancer with hmgb1 antagonists |
12/13/2012 | WO2012170720A2 Methods and compositions for treating brain cancer |
12/13/2012 | WO2012170664A2 Methods of cancer treatment and prevention through the modulation of sirt4 activity |
12/13/2012 | WO2012170573A2 New taccalonolide microtubule stabilizers |
12/13/2012 | WO2012170513A2 He4 based therapy for malignant disease |
12/13/2012 | WO2012170384A1 Use of metallocene compounds for cancer treatment |
12/13/2012 | WO2012170084A1 Composition and method for treating lung disease and mucous cell metaplasia |
12/13/2012 | WO2012170072A1 Engineered antibody-tnfsf member ligand fusion molecules |
12/13/2012 | WO2012169973A1 A core-shell nanoparticle |
12/13/2012 | WO2012169934A1 Novel kinase inhibitors |
12/13/2012 | WO2012169822A2 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
12/13/2012 | WO2012169785A2 Symmetrically structured quinazoline derivatives |
12/13/2012 | WO2012169733A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant |
12/13/2012 | WO2012169200A1 Sema5b peptides and vaccines including the same |
12/13/2012 | WO2012168908A1 Peptides for use in cancer treatment |
12/13/2012 | WO2012168885A2 Bisacodyl and analogues as drugs for treating cancer |
12/13/2012 | WO2012168884A1 Heterocyclic sulfonamide derivatives |
12/13/2012 | WO2012168721A1 Materials and methods for treating pten mutated or deficient cancer |
12/13/2012 | WO2012168720A1 MATERIALS AND METHODS FOR TREATING ESTROGEN RECEPTOR α (ER) POSITIVE CANCER |
12/13/2012 | WO2012168464A1 Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof |
12/13/2012 | WO2012168462A1 Antiinfective composition |
12/13/2012 | WO2012168401A1 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis |
12/13/2012 | WO2012168259A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer |
12/13/2012 | WO2012167944A1 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy |
12/13/2012 | WO2012167869A1 Amino lipids, their synthesis and uses thereof |
12/13/2012 | WO2012167733A1 Substituted pyridopyrazines as novel syk inhibitors |
12/13/2012 | WO2012167656A1 Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof |
12/13/2012 | WO2012167606A1 Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof |
12/13/2012 | WO2012167600A1 A heterocyclic [b]pyridone compound, intermediates thereof, method of preparation and uses |
12/13/2012 | WO2012167434A1 A pharmaceutical composition for inhibiting recurrence, aggravation and metastasis of hepatocarcinoma |
12/13/2012 | WO2012167415A1 Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof |
12/13/2012 | WO2012167382A1 Compositions and methods for glioblastoma treatment |
12/13/2012 | WO2012167368A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism |
12/13/2012 | WO2012167364A1 Phenolic compounds with antioxidant and anti-cancer properties, analogs and synthesis thereof |
12/13/2012 | WO2012151525A9 Novel compounds as modulators of protein kinases |
12/13/2012 | WO2012143499A3 Novel binder-drug conjugates (adcs) and their use |
12/13/2012 | WO2012143495A3 Novel binder-drug conjugates (adcs) and their use |
12/13/2012 | WO2012135637A3 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis |
12/13/2012 | WO2012131717A3 2',3'-epoxypropyl-3.4-dihydroxy benzene and a process for the preparation thereof |
12/13/2012 | WO2012126118A8 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
12/13/2012 | WO2012119010A3 Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer |
12/13/2012 | WO2012118353A3 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer |
12/13/2012 | WO2012094653A3 Compositions and methods for macromolecular drug delivery |
12/13/2012 | WO2012015677A9 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor |